High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.metabol.2008.07.032PMID 19013297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells.

  2006cited by this paper
• Endothelial and antithrombotic actions of HDL.

  2006cited by this paper
• Defective Metabolism of Oxidized Phospholipid by HDL From People With Type 2 Diabetes

  2006cited by this paper
• Impact of oxidized low density lipoprotein on vascular cells.

  2006cited by this paper
• Oxidative Reactive Species in Cell Injury: Mechanisms in Diabetes Mellitus and Therapeutic Approaches

  2005cited by this paper
• Oxidative inactivation of paraoxonase--implications in diabetes mellitus and atherosclerosis.

  2005cited by this paper
• High-density lipoprotein function recent advances.

  2005cited by this paper
• Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice.

  2005cited by this paper
• High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.

  2004cited by this paper
• Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells.

  2004cited by this paper
• Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation.

  2004cited by this paper
• Oxidative Stress and Antioxidant Treatment in Diabetes

  2004cited by this paper
• Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6.

  2003cited by this paper
• Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6

  2003cited by this paper
• Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice

  2002cited by this paper
• Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity

  2001cited by this paper
• Oxidized LDL and HDL: antagonists in atherothrombosis

  2001cited by this paper
• Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.

  2001cited by this paper
• Glucose enhancement of LDL oxidation is strictly metal ion dependent.

  2000cited by this paper
• Selective Attenuation of Metabolic Branch of Insulin Receptor Down-signaling by High Glucose in a Hepatoma Cell Line, HepG2 Cells*

  2000cited by this paper
• Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis*

  2000cited by this paper
• Glycation impairs high-density lipoprotein function

  2000cited by this paper
• Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.

  2000cited by this paper
• Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.

  1999cited by this paper
• Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat.

  1999cited by this paper
• Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat.

  1999cited by this paper
• Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells*

  1998cited by this paper
• Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

  1998cited by this paper
• Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.

  1998influential reference
• Molecular mechanisms of reverse cholesterol transport

  1996cited by this paper
• The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

  1996cited by this paper
• Glucose Metabolism to Glucosamine Is Necessary for Glucose Stimulation of Transforming Growth Factor-α Gene Transcription*

  1996cited by this paper
• The role of oxidized lipoproteins in atherogenesis.

  1996cited by this paper
• The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.

  1996cited by this paper
• Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

  1995cited by this paper
• Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.

  1995cited by this paper
• The oxidation hypothesis of atherosclerosis.

  1994cited by this paper
• Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.

  1994cited by this paper
• Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

  1993cited by this paper
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

  1993cited by this paper
• Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase.

  1993cited by this paper
• Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

  1991cited by this paper
• Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.

  1991cited by this paper
• Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat.

  1990cited by this paper
• Nonenzymatic Glucosylation of High-Density Lipoprotein Accelerates Its Catabolism in Guinea pigs

  1982cited by this paper

• Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review

  2023cites this paper
• High PON1 Expression Predicts Poor Prognosis In Kidney Renal Clear Cell Carcinoma

  2021cites this paper
• The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases

  2021cites this paper
• Novel cytotoxic amphiphilic nitro-compounds derived from a synthetic route for paraconic acids

  2021cites this paper
• Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders

  2019cites this paper
• Sitagliptin-Dependent Differences in the Intensity of Oxidative Stress in Rat Livers Subjected to Ischemia and Reperfusion

  2019cites this paper
• Correlation Between Serum PON1 Arylesterase Activity and Rs 854573 PON1 A < G Polymorphism with Type 2 Diabetes in an Eastern Indian Cohort

  2019cites this paper
• Caffeine Increases Apolipoprotein A-1 and Paraoxonase-1 but not Paraoxonase-3 Protein Levels in Human-Derived Liver (HepG2) Cells

  2017cites this paper
• Transcriptional regulation of human paraoxonase 1 by PXR and GR in human hepatoma cells.

  2015cites this paper
• La paraoxonase 1 : un marqueur de risque cardiovasculaire chez les jeunes diabétiques de type 1 ? (109 cas)

  2015cites this paper
• [Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes? (Study about 109 cases)].

  2015cites this paper
• Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome

  2015cites this paper
• Effects of culturing media on hepatocytes differentiation using Volvox sphere as co-culturing vehicle.

  2015cites this paper
• Paraoxonases function as unique protectors against cardiovascular diseases and diabetes: Updated experimental and clinical data

  2014cites this paper
• PEP-1-PON1 Protein Regulates Inflammatory Response in Raw 264.7 Macrophages and Ameliorates Inflammation in a TPA-Induced Animal Model

  2014cites this paper
• Factors Affecting Serum Paraoxonase 1 Activity in Migrant and Resident Gujarati South Asians

  2014cites this paper
• Investigation of heavy metal effects on immobilized paraoxanase by glutaraldehyde

  2013cites this paper
• Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

  2013cites this paper
• Regulation of Hepatic Paraoxonase-1 Expression

  2012cites this paper
• Antioxidant and Anti-Inflammatory Role of Paraoxonase 1: Implication in Arteriosclerosis Diseases

  2012influential citation
• Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study

  2012cites this paper
• Hypercholesterolaemia, signs of islet microangiopathy and altered angiogenesis precede onset of type 2 diabetes in the Goto–Kakizaki (GK) rat

  2011cites this paper
• Epigenetic DNA methylation in the promoters of the Igf1 receptor and insulin receptor genes in db/db mice

  2011cites this paper
• Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

  2011cites this paper
• The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.

  2010cites this paper